Lakhmir S Chawla
CIK 1646626 · Chief Medical Officer · last filed 2026-02-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$112
Companies
2
Total Filings
61
Lifetime Open-Market Net
$85.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| REVBW | Director | 12,158 | $0.01 | $112 | $0 | 4 | 2026-02-05 |
| LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Chief Medical Officer | 13,447 | $6.22 | $83.6K | $85.8K | 57 | 2020-09-17 |
Recent Filings · Page 3 of 7
61 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-01-17 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +498 | $3.3K | EDGAR |
| 2020-01-13 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-01-03 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +172 | $574 | EDGAR |
| 2019-12-17 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +201 | $573 | EDGAR |
| 2019-12-03 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +247 | $576 | EDGAR |
| 2019-11-19 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +111 | $568 | EDGAR |
| 2019-11-05 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +96 | $572 | EDGAR |
| 2019-10-17 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +81 | $577 | EDGAR |
| 2019-10-02 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +76 | $568 | EDGAR |
| 2019-09-16 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +62 | $575 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.